electroCore, Inc. (NASDAQ:ECOR) Position Boosted by International Assets Investment Management LLC

International Assets Investment Management LLC lifted its stake in electroCore, Inc. (NASDAQ:ECOR) by 49.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 53,020 shares of the company’s stock after purchasing an additional 17,620 shares during the quarter. International Assets Investment Management LLC owned 0.88% of electroCore worth $324,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Insider Transactions at electroCore

In other electroCore news, CEO Daniel S. Goldberger bought 38,505 shares of the stock in a transaction on Wednesday, June 5th. The shares were purchased at an average price of $6.43 per share, with a total value of $247,587.15. Following the acquisition, the chief executive officer now directly owns 249,565 shares of the company’s stock, valued at approximately $1,604,702.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 13.14% of the stock is currently owned by corporate insiders.

electroCore Trading Down 1.1 %

electroCore stock opened at $6.15 on Wednesday. The company has a market capitalization of $36.96 million, a P/E ratio of -2.16 and a beta of 0.60. electroCore, Inc. has a 1-year low of $3.83 and a 1-year high of $8.08. The firm’s fifty day simple moving average is $6.43 and its 200-day simple moving average is $6.44.

electroCore (NASDAQ:ECOR) last issued its quarterly earnings data on Wednesday, May 8th. The company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.03). electroCore had a negative net margin of 88.12% and a negative return on equity of 219.33%. The company had revenue of $5.44 million for the quarter, compared to analyst estimates of $5.18 million. On average, equities research analysts predict that electroCore, Inc. will post -1.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating on shares of electroCore in a report on Thursday, March 14th.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.